Prescribing Pharmacists: A Decision Maker Emerges

• Scope and Methodology
• Markets - Pharmacists Impact
• The Prescribing Pharmacist
• Main Drivers For Increased Pharmacist Prescription Authority
• Issues and Trends Shaping the Industry
• Methodology

Chapter Two: Introduction

• History and Description
• Role of the US Pharmacist
• Role in Distributing Controlled Substances
• Variations in Prescribing Authority
• Pharmacists Statistics
• Overview
• Earnings and Distribution by Employment Type
• State Concentrations
• Training and Certification

Chapter Three: Issues and Trends Shaping the Industry

• US Healthcare Expenditures
• Rising Healthcare Costs and Health Insurance Trends
• Pharmaceutical Trends
• Units Sales and Revenues of Top Branded Drugs
• Population Growth and the Existing Need
• Medication Safety
• Medication Errors
• Reducing Errors in Hospitals
• Drug Interactions
• Interactions and the Evolving Pharmaceutical Industry
• Prescribing Trends of Select Federal Programs
• State Comparison of Collaborative Practice
• Hospital Case Studies and Collaborative Drug Therapy Management
• HCA Hospitals
• Barriers to Collaborative Practice
• International Trends
• England
• Scotland
• Wales
• Northern Ireland
• Canada
• Japan
• Australia

Chapter Four: Pharmacist Impact on
Pharmaceutical Markets

• Overview
• The Pharmacist Influence
• Influencing Drug Choice
• Influencing Drug Dosage, Administration, or Other Therapy Aspects
• Therapeutic Areas Most Influenced
• chapter Five: The Emerging Prescribing Pharmacist
• Differing Views on Increasing Roles of the Pharmacist
• Physicians’ View on Increasing Involvement in Prescribing
• Pharmacists’ View on Increasing Involvement in Prescribing
• States Most Likely to Implement Independent Prescribing
• Market Impact

APPENDIX: Nationwide Boards of Pharmacy

table of exhibits

Chapter One: Executive Summary

• Figure  1-1: Declining Drug Purchases Not Influenced By Pharmacist 2006-2012
• Table 1-1: Pharmacists Influence in Drug Selection and/or Therapy Aspect: 2006 and 2012
• Figure 1-2: Pharmacists Influence in Drug Selection and/or Drug Aspect, 2006 and 2012

Chapter Two: Introduction

• Table 2-1: Examples of Controlled Substances by Schedule
• Table 2-2: Number of Pharmacists in the Workforce 2004-2006
• Table 2-3: 2004 Median Annual Income Levels for U.S. Pharmacists
• Figure 2-1: 2004 Median Annual Income Levels for U.S. Pharmacists
• Table 2-4: 2005 Leading Employment Areas and Income Statistics for U.S. Pharmacists
• Table 2-5: 2006 Leading Employment Areas and Income Statistics for U.S. Pharmacists
• Figure 2-2: Number of Pharmacists (2005/2006) in Leading Employment Areas in the U.S.
• Figure 2-3: Mean Level of Income (2005/2006) for Leading Employment Areas in the U.S.
• Table 2-6: Pharmacist Concentrations for the Top Five States in 2006
• Figure 2-4: Pharmacist Concentrations for the Top Five States in 2006
• Table 2-7: Pharmacist Concentrations for the Top Five U.S. Metropolitan Areas in 2006
• Figure 2-5: Pharmacist Concentrations for the Top Five U.S. Metropolitan Areas in 2006
• Table 2-8: Number of Pharmacists Employed in all U.S. States, District of Columbia and U.S. Territories in 2006
• Figure 2-6: Top 20 States with the Most Pharmacists in the Workforce in 2006 Table 2-9: Accredited Pharmacy Education Centers by State

Chapter ThreE: Issues and Trends Shaping the Industry

• Table 3-1: U.S. Prescription and Total Healthcare Expenditures 1995, 2000, and 2005
• Figure 3-1: U.S. Prescription and Total Healthcare Expenditures 1995, 2000, and 2005
• Table 3-2: Percent Insured in the U.S. by Income Level
• Figure 3-2: Percent Insured in the U.S. by Income Level
• Table 3-3: Health Insurance Trends in the United States 2003-2005
• Figure 3-3: Number Insured in the United States 2003-2005
• Table 3-4: Retail Pharmaceutical Sales in the U.S. 1995, 2000 and 2004
• Figure 3-4: Distribution of Retail Pharmaceutical Sales from 1995, 2000 and 2004
• Table 3-5: Top Ten Prescribed Branded Drugs by Estimated Unit Sales in the U.S.
• Table 3-5: Top Ten Prescribed Branded Drugs by Estimated Unit Sales in the U.S.
• Table 3-6: Top Ten Prescribed Branded Drugs and U.S. Revenues
• Figure 3-6: Top Ten Prescribed Branded Drugs and U.S. Revenues
• Table 3-7: Top Ten Prescribed Branded Drugs and Worldwide Revenues
• Figure 3-7: Top Ten Prescribed Branded Drugs and Worldwide Revenues
• Table 3-8: United States Population and Age Statistics
• Figure 3-8: United States Population and Age Statistics
• Table 3-9: Increase in the Oldest U.S. Population
• Figure 3-9: Increase in the Oldest U.S. Population
• Figure 3-10: Distribution of Fatal Prescribing Errors
• Table 3-10: Select 2007 Safety Alerts for Drugs and Therapeutic Biological Products
• Table 3-11: Drug Interaction Information
• Figure 3-11: Timeline of U.S. Pharmacy Collaboration
• Table 3-12: States That Allow Collaboration Agreements between Pharmacist and Physician
• Table 3-13: Pharmacists per Employment Category in Japan (2004)

Chapter Four: Pharmacist Impact on Pharmaceutical Markets

• Table 4-1: Pharmacists Influence in Drug Selection and/or Drug Therapy Aspect, 2006 and 2012
• Figure 4-1 : Pharmacists Influence in Drug Selection and/or Therapy Aspect, 2006 and 2012
• Table 4-2: Pharmacists Influence in the US Drug Market, Influencing Drug Choice, 2006
• Figure 4-2: Pharmacists Influence in the US Drug Market, Influencing Drug Choice, 2006
• Figure 4-3: Drug Markets Most Influenced by Pharmacists by  Therapeutic Category, 2006
• Table 4-3: Pharmacists Influence in the US Drug Market, Influencing Drug Dosage, Administration, and Other Therapy Aspect, 2006
• Figure 4-3: Pharmacists Influence in the US Drug Market, Influencing Drug Dosage, Administration, and Other Therapy Aspect, 2006

chapter Five: The Emerging Prescribing Pharmacist

• Table 5-1: States Most Likely to Allow Prescription, Those to Follow, and States Not Likely to Allow Independent Prescribing